Thank you to Moira Gunn and @BioTechNation for featuring Dan Schmitt, President and CEO of @ActuateThera on this week’s episode timed to the @ASCO Annual Meeting in Chicago.
Dan discusses elraglusib and Actuate’s work in hard-to-treat cancers, including adult pancreatic cancer and two pediatric cancers. Listen here: lnkd.in/gzfEmnmc
#ASCO #ASCO26 #Oncology #PancreaticCancer #BioTechNation
1
48
Apr 30
Dr. Moira Gunn from @biotechnation interviewed @AndrewFarnum and Dr. Sarah LeBaron von Baeyer from @VariantBio for NPR this week on how AI, ethics, and diverse data can help us develop better drugs and diagnostics: medium.com/variantbio/varian…
1
1
103
Apr 29
"I have never met anyone before whose job just it is constantly changing every second... The tsunami of data coming in." - @biotechnation . 🌎🔍 What We Ask Google drops May 5th.
open.spotify.com/episode/1jA…
334
Apr 29
Thank you for hosting a great conversation on our work @VariantBio, Dr. Moira Gunn! @biotechnation biotechnation.com/episodes/t…
1
2
126
Apr 28
Alpha in biotech comes from looking where no one else is. At @VariantBio, we’ve built a proprietary engine to uncover human genetic evidence that the rest of the industry is missing. I had a great deep dive into the ethics and science of our approach on @biotechnation today.
1
1
2
223
Mar 23
NervGen’s CEO, Dr. Adam Rogers, joined @biotechnation to share the story behind NVG-291, from Dr. Jerry Silver’s pioneering research and Harold Punnett’s founding vision to what NervGen’s CONNECT SCI clinical data now shows is possible for individuals living with chronic spinal cord injury.
biotechnation.com/episodes/r…
#SCI #SpinalCordInjury
9
28
1,094
Mar 20
Our CEO Arun Swaminathan, Ph.D., recently joined Moira Gunn on NPR’s #BioTechNation to discuss Coya’s work advancing a novel approach to treating #ALS. Tune in to hear more about the science and vision behind Coya’s work: biotechnation.com/episodes/a…
1
1
143
Jan 15
At Tris Pharma, we’re advancing treatments for ADHD, pain, and CNS disorders that can meaningfully improve lives. Our Founder & CEO, Ketan Mehta, joined @BioTechNation to discuss our dual-receptor (MOP/NOP) approach to pain.
🎙️Listen: biotechnation.com/episodes/a…
1
253
Talking to @biotechnation took me back to why Gordian got started. In 2018, after years at the NIH and Buck Institute, I returned a $1M K99/R00 grant because I realized that starting a lab to study inflammation had very little chance to help over-65s living with multiple chronic diseases (like my parents)...
1
1
8
872
Honored to be featured by Moira Gunn of @NPR's #BioTechNation as one of the Top 5 JPM interviews. In this special edition, Augurex shares how we’re closing gaps in back pain and axSpA care, where patients often wait 7–10 years for answers. #JPM2026 podcasts.apple.com/us/podcas…
1
2
84
In traditional target discovery, we have pick one gene target out of the >20,000 in the human genome and spend millions of dollars to see if it was a good choice.
But solving aging will take too long if we keep relying on a single candidate that might not even be the right one. @leportfr and I sat down with @biotechnation to talk about how @GordianBio does things differently. (Link below)
1
1
6
462
5 Dec 2025
This week on #BioTechNation, Dr. Daniel Kraft tells us that we’re moving from Dr. Google to Dr. ChatGPT.
Listen Now: biotechnation.com/episodes/a…
1
2
139
20 Nov 2025
What inspires our work at AviadoBio?
In the latest episode of @BioTechNation, our CEO Lisa Deschamps discusses our team's mission and commitment to developing one-time gene therapies for neurodegenerative diseases.
Listen here: biotechnation.com/episodes/c…
#Biotech
2
1,273
19 Nov 2025
Latest episode of @Biotechnation where I explore with Moira Gunn the cutting edge and future of #Proteomics and new evidence of a 'Dark Proteome'.
podomatic.com/podcasts/techn…
2
559
19 Nov 2025
This week on #BioTechNation, Lisa Deschamps, CEO of Aviado Bio, tells us how her team is working to correct the gene driving many cases of frontotemporal dementia.
Listen Now: biotechnation.com/episodes/c…
1
148
12 Nov 2025
Featured on #BioTechNation, Dr. Derek Jantz, Chief Scientific Officer at Tune Therapeutics, joins me to talk about the ability to tune your genome. Tune Therapeutics looks to tune out Hepatitis B!
Listen now: biotechnation.com/episodes/t…
1
125
5 Nov 2025
Our CMO Dr. Ned Swanson joins #BioTechNation to discuss the company’s regenerative approach to healing serious skin wounds, such as chronic conditions like #DFUs. Tune in ~43:30 mark: bit.ly/43OIANx #Biotech #RegenerativeMedicine
SkinTE is for investigational use only.
6
5 Nov 2025
Featured on #BioTechNation, Dr. Ned Swanson, Co-Founder, President, and Chief Medical Officer of Polarity Bio, joins me to talk about a new approach to treating wounds.
Listen now - biotechnation.com/episodes/a…
1
108
29 Oct 2025
Featured on #BioTechNation, Rob Armstrong, CEO of Artax Biopharma Inc., joins me to talk about treating the 40% of all rheumatoid arthritis patients who do not respond to any current drugs.
Listen now: biotechnation.com/episodes/t…
1
130
22 Oct 2025
Featured on #BioTechNation, Dr. Joshua Hare, Co-Founder and Chief Scientific Officer of Longeveron, joins me to talk about how they are testing the use of stem cells to treat babies born with a serious congenital heart defect.
Listen now: biotechnation.com/episodes/t…
1
1
218